SB 2526                                          First Engrossed
       
       
       
       
       
       
       
       
       20222526e1
       
    1                        A bill to be entitled                      
    2         An act relating to health; amending s. 17.41, F.S.;
    3         providing that the Department of Financial Services
    4         Tobacco Settlement Clearing Trust Fund shall be
    5         referred to as the “Lawton Chiles Trust Fund”;
    6         amending s. 210.201, F.S.; providing an appropriation
    7         to the Board of Directors of the H. Lee Moffitt Cancer
    8         Center and Research Institute for a specified purpose;
    9         authorizing such appropriation to be used to secure
   10         certain financing; providing construction; amending s.
   11         381.02035, F.S.; authorizing pharmacists and
   12         wholesalers employed by or under contract with
   13         forensic facilities managed by the Agency for Persons
   14         with Disabilities to import prescription drugs under
   15         the Canadian Prescription Drug Importation Program for
   16         dispensing to clients in such facilities; amending s.
   17         381.915, F.S.; renaming the Florida Consortium of
   18         National Cancer Institute Centers Program as the
   19         “Casey DeSantis Cancer Research Program”; revising a
   20         short title; amending s. 394.9082, F.S.; requiring
   21         that the Department of Children and Families’
   22         contracts with managing entities be made available on
   23         the department’s website; requiring the department to
   24         conduct a specified review of managing entities every
   25         2 years; requiring the department to submit the review
   26         to the Governor and the Legislature by a specified
   27         date; requiring managing entities to provide notice to
   28         providers before removing the provider from the
   29         provider network; amending s. 409.814, F.S.; providing
   30         for continued Title XXI-funded coverage for certain
   31         enrollees beyond 19 years of age under certain
   32         circumstances; providing for eligibility; amending s.
   33         409.908, F.S.; requiring the agency to base its rate
   34         of payments for nursing home care in its Title XIX
   35         Long-Term Care Reimbursement Plan in accordance with
   36         specified minimum wage requirements; amending ss.
   37         20.435, 210.20, and 409.816, F.S.; conforming
   38         provisions to changes made by the act; providing an
   39         effective date.
   40          
   41  Be It Enacted by the Legislature of the State of Florida:
   42  
   43         Section 1. Subsection (1) of section 17.41, Florida
   44  Statutes, is amended to read:
   45         17.41 Department of Financial Services Tobacco Settlement
   46  Clearing Trust Fund.—
   47         (1) The Department of Financial Services Tobacco Settlement
   48  Clearing Trust Fund, which shall be referred to as the “Lawton
   49  Chiles Trust Fund,” is created within that department.
   50         Section 2. Section 210.201, Florida Statutes, is amended to
   51  read:
   52         210.201 H. Lee Moffitt Cancer Center and Research Institute
   53  facilities; establishment; funding.—
   54         (1) The Board of Directors of the H. Lee Moffitt Cancer
   55  Center and Research Institute shall construct, furnish, and
   56  equip, and shall covenant to complete, the cancer research and
   57  clinical and related facilities of the H. Lee Moffitt Cancer
   58  Center and Research Institute funded with proceeds from the
   59  Cigarette Tax Collection Trust Fund pursuant to s. 210.20.
   60  Moneys transferred to the Board of Directors of the H. Lee
   61  Moffitt Cancer Center and Research Institute pursuant to s.
   62  210.20 may be used to secure financing to pay costs related to
   63  constructing, furnishing, equipping, operating, and maintaining
   64  cancer research and clinical and related facilities; furnishing,
   65  equipping, operating, and maintaining other leased or owned
   66  properties; and paying costs incurred in connection with
   67  purchasing, financing, operating, and maintaining such
   68  equipment, facilities, and properties as provided in s. 210.20.
   69  Such financing may include the issuance of tax-exempt bonds or
   70  other forms of indebtedness by a local authority, municipality,
   71  or county pursuant to parts II and III of chapter 159. Such
   72  bonds shall not constitute state bonds for purposes of s. 11,
   73  Art. VII of the State Constitution, but shall constitute bonds
   74  of a local agency,” as defined in s. 159.27(4). The cigarette
   75  tax dollars pledged to facilities pursuant to s. 210.20 may be
   76  replaced annually by the Legislature from tobacco litigation
   77  settlement proceeds.
   78         (2) Beginning in the 2022-2023 fiscal year, and annually
   79  through the 2052-2053 fiscal year, the sum of $20 million is
   80  appropriated and shall be transferred to the Board of Directors
   81  of the H. Lee Moffitt Cancer Center and Research Institute for
   82  construction and development of Moffitt’s Pasco County life
   83  sciences park. Moneys transferred to the Board of Directors of
   84  the H. Lee Moffitt Cancer Center and Research Institute pursuant
   85  to this subsection may be used to secure financing to pay costs
   86  related to the construction and development of Moffitt’s Pasco
   87  County life sciences park. Such financing may include the
   88  issuance of tax-exempt bonds or other forms of indebtedness by a
   89  local authority, municipality, or county pursuant to parts II
   90  and III of chapter 159. Such bonds shall not constitute state
   91  bonds for purposes of s. 11, Art. VII of the State Constitution,
   92  but shall constitute bonds of a local agency as defined in s.
   93  159.27(4).
   94         Section 3. Paragraph (f) is added to subsection (7) of
   95  section 381.02035, Florida Statutes, to read:
   96         381.02035 Canadian Prescription Drug Importation Program.—
   97         (7) ELIGIBLE IMPORTERS.—The following entities may import
   98  prescription drugs from an eligible Canadian supplier under the
   99  program:
  100         (f) A pharmacist or wholesaler employed by or under
  101  contract with a forensic facility, as defined in s. 916.106,
  102  that is managed by the Agency for Persons with Disabilities, for
  103  dispensing to clients treated in such facility.
  104         Section 4. Section 381.915, Florida Statutes, is amended to
  105  read:
  106         381.915 Casey DeSantis Cancer Research Florida Consortium
  107  of National Cancer Institute Centers Program.—
  108         (1) This section may be cited as the “Casey DeSantis Cancer
  109  Research Florida NCI Cancer Centers Act.”
  110         (2) The Casey DeSantis Cancer Research Florida Consortium
  111  of National Cancer Institute Centers Program is established to
  112  enhance the quality and competitiveness of cancer care in this
  113  state, further a statewide biomedical research strategy directly
  114  responsive to the health needs of Florida’s citizens, and
  115  capitalize on the potential educational opportunities available
  116  to its students. The department shall make payments to Florida
  117  based cancer centers recognized by the National Cancer Institute
  118  (NCI) at the National Institutes of Health as NCI-designated
  119  cancer centers or NCI-designated comprehensive cancer centers,
  120  and cancer centers working toward achieving NCI designation. The
  121  department shall distribute funds to participating cancer
  122  centers on a quarterly basis during each fiscal year for which
  123  an appropriation is made.
  124         (3) On or before September 15 of each year, the department
  125  shall calculate an allocation fraction to be used for
  126  distributing funds to participating cancer centers. On or before
  127  the final business day of each quarter of the state fiscal year,
  128  the department shall distribute to each participating cancer
  129  center one-fourth of that cancer center’s annual allocation
  130  calculated under subsection (6). The allocation fraction for
  131  each participating cancer center is based on the cancer center’s
  132  tier-designated weight under subsection (4) multiplied by each
  133  of the following allocation factors: number of reportable cases,
  134  peer-review costs, and biomedical education and training. As
  135  used in this section, the term:
  136         (a) “Biomedical education and training” means instruction
  137  that is offered to a student who is enrolled in a biomedical
  138  research program at an affiliated university as a medical
  139  student or a student in a master’s or doctoral degree program,
  140  or who is a resident physician trainee or postdoctoral trainee
  141  in such program. An affiliated university biomedical research
  142  program must be accredited or approved by a nationally
  143  recognized agency and offered through an institution accredited
  144  by the Commission on Colleges of the Southern Association of
  145  Colleges and Schools. Full-time equivalency for trainees shall
  146  be prorated for training received in oncologic sciences and
  147  oncologic medicine.
  148         (b) “Cancer center” means a freestanding center, a center
  149  situated within an academic institution, or a formal research
  150  based consortium under centralized leadership that has achieved
  151  NCI designation or is prepared to achieve NCI designation by
  152  July 1, 2019.
  153         (c) “Florida-based” means that a cancer center’s actual or
  154  sought designated status is or would be recognized by the NCI as
  155  primarily located in Florida and not in another state.
  156         (d) “Peer-review costs” means the total annual direct costs
  157  for peer-reviewed cancer-related research projects, consistent
  158  with reporting guidelines provided by the NCI, for the most
  159  recent annual reporting period available.
  160         (e) “Reportable cases” means cases of cancer in which a
  161  cancer center is involved in the diagnosis, evaluation of the
  162  diagnosis, evaluation of the extent of cancer spread at the time
  163  of diagnosis, or administration of all or any part of the first
  164  course of therapy for the most recent annual reporting period
  165  available. Cases relating to patients enrolled in institutional
  166  or investigator-initiated interventional clinical trials shall
  167  be weighted at 1.2 relative to other cases weighted at 1.0.
  168  Determination of institutional or investigator-initiated
  169  interventional clinical trials must be consistent with reporting
  170  guidelines provided by the NCI.
  171         (4) Tier designations and corresponding weights within the
  172  Casey DeSantis Cancer Research Florida Consortium of National
  173  Cancer Institute Centers Program are as follows:
  174         (a) Tier 1: Florida-based NCI-designated comprehensive
  175  cancer centers, which shall be weighted at 1.5.
  176         (b) Tier 2: Florida-based NCI-designated cancer centers,
  177  which shall be weighted at 1.25.
  178         (c) Tier 3: Florida-based cancer centers seeking
  179  designation as either a NCI-designated cancer center or NCI
  180  designated comprehensive cancer center, which shall be weighted
  181  at 1.0.
  182         1. A cancer center shall meet the following minimum
  183  criteria to be considered eligible for Tier 3 designation in any
  184  given fiscal year:
  185         a. Conducting cancer-related basic scientific research and
  186  cancer-related population scientific research;
  187         b. Offering and providing the full range of diagnostic and
  188  treatment services on site, as determined by the Commission on
  189  Cancer of the American College of Surgeons;
  190         c. Hosting or conducting cancer-related interventional
  191  clinical trials that are registered with the NCI’s Clinical
  192  Trials Reporting Program;
  193         d. Offering degree-granting programs or affiliating with
  194  universities through degree-granting programs accredited or
  195  approved by a nationally recognized agency and offered through
  196  the center or through the center in conjunction with another
  197  institution accredited by the Commission on Colleges of the
  198  Southern Association of Colleges and Schools;
  199         e. Providing training to clinical trainees, medical
  200  trainees accredited by the Accreditation Council for Graduate
  201  Medical Education or the American Osteopathic Association, and
  202  postdoctoral fellows recently awarded a doctorate degree; and
  203         f. Having more than $5 million in annual direct costs
  204  associated with their total NCI peer-reviewed grant funding.
  205         2. The General Appropriations Act or accompanying
  206  legislation may limit the number of cancer centers which shall
  207  receive Tier 3 designations or provide additional criteria for
  208  such designation.
  209         3. A cancer center’s participation in Tier 3 may not extend
  210  beyond June 30, 2024.
  211         4. A cancer center that qualifies as a designated Tier 3
  212  center under the criteria provided in subparagraph 1. by July 1,
  213  2014, is authorized to pursue NCI designation as a cancer center
  214  or a comprehensive cancer center until June 30, 2024.
  215         (5) The department shall use the following formula to
  216  calculate a participating cancer center’s allocation fraction:
  217  
  218       CAF=[0.4x(CRC÷TCRC)]+[0.3x(CPC÷TCPC)]+[0.3x(CBE÷TCBE)]      
  219  
  220         Where:
  221         CAF=A cancer center’s allocation fraction.
  222         CRC=A cancer center’s tier-weighted reportable cases.
  223         TCRC=The total tier-weighted reportable cases for all
  224  cancer centers.
  225         CPC=A cancer center’s tier-weighted peer-review costs.
  226         TCPC=The total tier-weighted peer-review costs for all
  227  cancer centers.
  228         CBE=A cancer center’s tier-weighted biomedical education
  229  and training.
  230         TCBE=The total tier-weighted biomedical education and
  231  training for all cancer centers.
  232  
  233         (6) A cancer center’s annual allocation shall be calculated
  234  by multiplying the funds appropriated for the Casey DeSantis
  235  Cancer Research Florida Consortium of National Cancer Institute
  236  Centers Program in the General Appropriations Act by that cancer
  237  center’s allocation fraction. If the calculation results in an
  238  annual allocation that is less than $16 million, that cancer
  239  center’s annual allocation shall be increased to a sum equaling
  240  $16 million, with the additional funds being provided
  241  proportionally from the annual allocations calculated for the
  242  other participating cancer centers.
  243         (7) Beginning July 1, 2017, and every 3 years thereafter,
  244  the department, in conjunction with participating cancer
  245  centers, shall submit a report to the Cancer Control and
  246  Research Advisory Council on specific metrics relating to cancer
  247  mortality and external funding for cancer-related research in
  248  the state. If a cancer center does not endorse this report or
  249  produce an equivalent independent report, the cancer center
  250  shall be suspended from the program for 1 year. The report must
  251  include:
  252         (a) An analysis of trending age-adjusted cancer mortality
  253  rates in the state, which must include, at a minimum, overall
  254  age-adjusted mortality rates for cancer statewide and age
  255  adjusted mortality rates by age group, geographic region, and
  256  type of cancer, which must include, at a minimum:
  257         1. Lung cancer.
  258         2. Pancreatic cancer.
  259         3. Sarcoma.
  260         4. Melanoma.
  261         5. Leukemia and myelodysplastic syndromes.
  262         6. Brain cancer.
  263         (b) Identification of trends in overall federal funding,
  264  broken down by institutional source, for cancer-related research
  265  in the state.
  266         (c) A list and narrative description of collaborative
  267  grants and interinstitutional collaboration among participating
  268  cancer centers, a comparison of collaborative grants in
  269  proportion to the grant totals for each cancer center, a
  270  catalogue of retreats and progress seed grants using state
  271  funds, and targets for collaboration in the future and reports
  272  on progress regarding such targets where appropriate.
  273         (8) This section is subject to annual appropriation by the
  274  Legislature.
  275         (9) The department may adopt rules to administer this
  276  section.
  277         Section 5. Paragraph (i) of subsection (5) of section
  278  394.9082, Florida Statutes, is amended, and paragraphs (k) and
  279  (l) are added to subsection (4) of that section, to read:
  280         394.9082 Behavioral health managing entities.—
  281         (4) CONTRACT WITH MANAGING ENTITIES.—
  282         (k) The department’s contracts with managing entities must
  283  be made available in a publicly accessible format on the
  284  department’s website.
  285         (l) Every 2 years, the department shall conduct a
  286  comprehensive, multiyear review of the revenues, expenditures,
  287  and financial positions of managing entities covering the most
  288  recent 2 consecutive fiscal years. The review must include a
  289  comprehensive system-of-care analysis. The department shall
  290  submit the review to the Governor, the President of the Senate,
  291  and the Speaker of the House of Representatives by November 1 of
  292  every other year, beginning in 2023.
  293         (5) MANAGING ENTITY DUTIES.—A managing entity shall:
  294         (i) Develop a comprehensive provider network of qualified
  295  providers to deliver behavioral health services. The managing
  296  entity is not required to competitively procure network
  297  providers but shall publicize opportunities to join the provider
  298  network and evaluate providers in the network to determine if
  299  they may remain in the network. A managing entity must provide
  300  notice to a provider before the provider is removed from the
  301  network. The managing entity shall publish these processes on
  302  its website. The managing entity shall ensure continuity of care
  303  for clients if a provider ceases to provide a service or leaves
  304  the network.
  305         Section 6. Present subsections (4) through (11) of section
  306  409.814, Florida Statutes, are redesignated as subsections (5)
  307  through (12), respectively, a new subsection (4) is added to
  308  that section, and present subsections (5), (6), and (10) are
  309  amended, to read:
  310         409.814 Eligibility.—A child who has not reached 19 years
  311  of age whose family income is equal to or below 200 percent of
  312  the federal poverty level is eligible for the Florida Kidcare
  313  program as provided in this section. If an enrolled individual
  314  is determined to be ineligible for coverage, he or she must be
  315  immediately disenrolled from the respective Florida Kidcare
  316  program component.
  317         (4) A Title XXI-funded child who reaches 19 years of age is
  318  eligible for continued Title XXI-funded coverage for the
  319  duration of a pregnancy and the postpartum period consisting of
  320  the 12-month period beginning on the last day of a pregnancy, if
  321  such pregnancy or postpartum period begins prior to the child
  322  reaching 19 years of age, and if the child is ineligible for
  323  Medicaid.
  324         (6)(5) A child who is otherwise eligible for the Florida
  325  Kidcare program and who has a preexisting condition that
  326  prevents coverage under another insurance plan as described in
  327  paragraph (5)(a)(4)(a) which would have disqualified the child
  328  for the Florida Kidcare program if the child were able to enroll
  329  in the plan is eligible for Florida Kidcare coverage when
  330  enrollment is possible.
  331         (7)(6) A child whose family income is above 200 percent of
  332  the federal poverty level or a child who is excluded under the
  333  provisions of subsection (5)(4) may participate in the Florida
  334  Kidcare program as provided in s. 409.8132 or, if the child is
  335  ineligible for Medikids by reason of age, in the Florida Healthy
  336  Kids program, subject to the following:
  337         (a) The family is not eligible for premium assistance
  338  payments and must pay the full cost of the premium, including
  339  any administrative costs.
  340         (b) The board of directors of the Florida Healthy Kids
  341  Corporation may offer a reduced benefit package to these
  342  children in order to limit program costs for such families.
  343         (11)(10) Subject to paragraph (5)(a)(4)(a), the Florida
  344  Kidcare program shall withhold benefits from an enrollee if the
  345  program obtains evidence that the enrollee is no longer
  346  eligible, submitted incorrect or fraudulent information in order
  347  to establish eligibility, or failed to provide verification of
  348  eligibility. The applicant or enrollee shall be notified that
  349  because of such evidence program benefits will be withheld
  350  unless the applicant or enrollee contacts a designated
  351  representative of the program by a specified date, which must be
  352  within 10 working days after the date of notice, to discuss and
  353  resolve the matter. The program shall make every effort to
  354  resolve the matter within a timeframe that will not cause
  355  benefits to be withheld from an eligible enrollee.
  356         Section 7. Subsection (2) of section 409.908, Florida
  357  Statutes, is amended to read:
  358         409.908 Reimbursement of Medicaid providers.—Subject to
  359  specific appropriations, the agency shall reimburse Medicaid
  360  providers, in accordance with state and federal law, according
  361  to methodologies set forth in the rules of the agency and in
  362  policy manuals and handbooks incorporated by reference therein.
  363  These methodologies may include fee schedules, reimbursement
  364  methods based on cost reporting, negotiated fees, competitive
  365  bidding pursuant to s. 287.057, and other mechanisms the agency
  366  considers efficient and effective for purchasing services or
  367  goods on behalf of recipients. If a provider is reimbursed based
  368  on cost reporting and submits a cost report late and that cost
  369  report would have been used to set a lower reimbursement rate
  370  for a rate semester, then the provider’s rate for that semester
  371  shall be retroactively calculated using the new cost report, and
  372  full payment at the recalculated rate shall be effected
  373  retroactively. Medicare-granted extensions for filing cost
  374  reports, if applicable, shall also apply to Medicaid cost
  375  reports. Payment for Medicaid compensable services made on
  376  behalf of Medicaid-eligible persons is subject to the
  377  availability of moneys and any limitations or directions
  378  provided for in the General Appropriations Act or chapter 216.
  379  Further, nothing in this section shall be construed to prevent
  380  or limit the agency from adjusting fees, reimbursement rates,
  381  lengths of stay, number of visits, or number of services, or
  382  making any other adjustments necessary to comply with the
  383  availability of moneys and any limitations or directions
  384  provided for in the General Appropriations Act, provided the
  385  adjustment is consistent with legislative intent.
  386         (2)(a)1. Reimbursement to nursing homes licensed under part
  387  II of chapter 400 and state-owned-and-operated intermediate care
  388  facilities for the developmentally disabled licensed under part
  389  VIII of chapter 400 must be made prospectively.
  390         2. Unless otherwise limited or directed in the General
  391  Appropriations Act, reimbursement to hospitals licensed under
  392  part I of chapter 395 for the provision of swing-bed nursing
  393  home services must be made on the basis of the average statewide
  394  nursing home payment, and reimbursement to a hospital licensed
  395  under part I of chapter 395 for the provision of skilled nursing
  396  services must be made on the basis of the average nursing home
  397  payment for those services in the county in which the hospital
  398  is located. When a hospital is located in a county that does not
  399  have any community nursing homes, reimbursement shall be
  400  determined by averaging the nursing home payments in counties
  401  that surround the county in which the hospital is located.
  402  Reimbursement to hospitals, including Medicaid payment of
  403  Medicare copayments, for skilled nursing services shall be
  404  limited to 30 days, unless a prior authorization has been
  405  obtained from the agency. Medicaid reimbursement may be extended
  406  by the agency beyond 30 days, and approval must be based upon
  407  verification by the patient’s physician that the patient
  408  requires short-term rehabilitative and recuperative services
  409  only, in which case an extension of no more than 15 days may be
  410  approved. Reimbursement to a hospital licensed under part I of
  411  chapter 395 for the temporary provision of skilled nursing
  412  services to nursing home residents who have been displaced as
  413  the result of a natural disaster or other emergency may not
  414  exceed the average county nursing home payment for those
  415  services in the county in which the hospital is located and is
  416  limited to the period of time which the agency considers
  417  necessary for continued placement of the nursing home residents
  418  in the hospital.
  419         (b) Subject to any limitations or directions in the General
  420  Appropriations Act, the agency shall establish and implement a
  421  state Title XIX Long-Term Care Reimbursement Plan for nursing
  422  home care in order to provide care and services in conformance
  423  with the applicable state and federal laws, rules, regulations,
  424  and quality and safety standards and to ensure that individuals
  425  eligible for medical assistance have reasonable geographic
  426  access to such care.
  427         1. The agency shall amend the long-term care reimbursement
  428  plan and cost reporting system to create direct care and
  429  indirect care subcomponents of the patient care component of the
  430  per diem rate. These two subcomponents together shall equal the
  431  patient care component of the per diem rate. Separate prices
  432  shall be calculated for each patient care subcomponent,
  433  initially based on the September 2016 rate setting cost reports
  434  and subsequently based on the most recently audited cost report
  435  used during a rebasing year. The direct care subcomponent of the
  436  per diem rate for any providers still being reimbursed on a cost
  437  basis shall be limited by the cost-based class ceiling, and the
  438  indirect care subcomponent may be limited by the lower of the
  439  cost-based class ceiling, the target rate class ceiling, or the
  440  individual provider target. The ceilings and targets apply only
  441  to providers being reimbursed on a cost-based system. Effective
  442  October 1, 2018, a prospective payment methodology shall be
  443  implemented for rate setting purposes with the following
  444  parameters:
  445         a. Peer Groups, including:
  446         (I) North-SMMC Regions 1-9, less Palm Beach and Okeechobee
  447  Counties; and
  448         (II) South-SMMC Regions 10-11, plus Palm Beach and
  449  Okeechobee Counties.
  450         b. Percentage of Median Costs based on the cost reports
  451  used for September 2016 rate setting:
  452         (I) Direct Care Costs........................100 percent.
  453         (II) Indirect Care Costs......................92 percent.
  454         (III) Operating Costs.........................86 percent.
  455         c. Floors:
  456         (I) Direct Care Component.....................95 percent.
  457         (II) Indirect Care Component................92.5 percent.
  458         (III) Operating Component...........................None.
  459         d. Pass-through Payments..................Real Estate and
  460  ...............................................Personal Property
  461  ...................................Taxes and Property Insurance.
  462         e. Quality Incentive Program Payment
  463  Pool......................................6 percent of September
  464  .......................................2016 non-property related
  465  ................................payments of included facilities.
  466         f. Quality Score Threshold to Quality for Quality Incentive
  467  Payment..................20th percentile of included facilities.
  468         g. Fair Rental Value System Payment Parameters:
  469         (I) Building Value per Square Foot based on 2018 RS Means.
  470         (II) Land Valuation...10 percent of Gross Building value.
  471         (III) Facility Square Footage......Actual Square Footage.
  472         (IV) Moveable Equipment Allowance.........$8,000 per bed.
  473         (V) Obsolescence Factor......................1.5 percent.
  474         (VI) Fair Rental Rate of Return................8 percent.
  475         (VII) Minimum Occupancy.......................90 percent.
  476         (VIII) Maximum Facility Age.....................40 years.
  477         (IX) Minimum Square Footage per Bed..................350.
  478         (X) Maximum Square Footage for Bed...................500.
  479         (XI) Minimum Cost of a renovation/replacements$500 per bed.
  480         h. Ventilator Supplemental payment of $200 per Medicaid day
  481  of 40,000 ventilator Medicaid days per fiscal year.
  482         2. The direct care subcomponent shall include salaries and
  483  benefits of direct care staff providing nursing services
  484  including registered nurses, licensed practical nurses, and
  485  certified nursing assistants who deliver care directly to
  486  residents in the nursing home facility, allowable therapy costs,
  487  and dietary costs. This excludes nursing administration, staff
  488  development, the staffing coordinator, and the administrative
  489  portion of the minimum data set and care plan coordinators. The
  490  direct care subcomponent also includes medically necessary
  491  dental care, vision care, hearing care, and podiatric care.
  492         3. All other patient care costs shall be included in the
  493  indirect care cost subcomponent of the patient care per diem
  494  rate, including complex medical equipment, medical supplies, and
  495  other allowable ancillary costs. Costs may not be allocated
  496  directly or indirectly to the direct care subcomponent from a
  497  home office or management company.
  498         4. On July 1 of each year, the agency shall report to the
  499  Legislature direct and indirect care costs, including average
  500  direct and indirect care costs per resident per facility and
  501  direct care and indirect care salaries and benefits per category
  502  of staff member per facility.
  503         5. Every fourth year, the agency shall rebase nursing home
  504  prospective payment rates to reflect changes in cost based on
  505  the most recently audited cost report for each participating
  506  provider.
  507         6. A direct care supplemental payment may be made to
  508  providers whose direct care hours per patient day are above the
  509  80th percentile and who provide Medicaid services to a larger
  510  percentage of Medicaid patients than the state average.
  511         7. For the period beginning on October 1, 2018, and ending
  512  on September 30, 2021, the agency shall reimburse providers the
  513  greater of their September 2016 cost-based rate or their
  514  prospective payment rate. Effective October 1, 2021, the agency
  515  shall reimburse providers the greater of 95 percent of their
  516  cost-based rate or their rebased prospective payment rate, using
  517  the most recently audited cost report for each facility. This
  518  subparagraph shall expire September 30, 2023.
  519         8. Pediatric, Florida Department of Veterans Affairs, and
  520  government-owned facilities are exempt from the pricing model
  521  established in this subsection and shall remain on a cost-based
  522  prospective payment system. Effective October 1, 2018, the
  523  agency shall set rates for all facilities remaining on a cost
  524  based prospective payment system using each facility’s most
  525  recently audited cost report, eliminating retroactive
  526  settlements.
  527  
  528  It is the intent of the Legislature that the reimbursement plan
  529  achieve the goal of providing access to health care for nursing
  530  home residents who require large amounts of care while
  531  encouraging diversion services as an alternative to nursing home
  532  care for residents who can be served within the community. The
  533  agency shall base the establishment of any maximum rate of
  534  payment, whether overall or component, on the available moneys
  535  as provided for in the General Appropriations Act. The agency
  536  may base the maximum rate of payment on the results of
  537  scientifically valid analysis and conclusions derived from
  538  objective statistical data pertinent to the particular maximum
  539  rate of payment. The agency shall base the rates of payments in
  540  accordance with the minimum wage requirements as provided in the
  541  General Appropriations Act.
  542         Section 8. Paragraph (a) of subsection (7) of section
  543  20.435, Florida Statutes, is amended to read:
  544         20.435 Department of Health; trust funds.—The following
  545  trust funds shall be administered by the Department of Health:
  546         (7) Biomedical Research Trust Fund.
  547         (a) Funds to be credited to the trust fund shall consist of
  548  funds appropriated by the Legislature. Funds shall be used for
  549  the purposes of the James and Esther King Biomedical Research
  550  Program, the Casey DeSantis Cancer Research Florida Consortium
  551  of National Cancer Institute Centers Program, and the William G.
  552  “Bill” Bankhead, Jr., and David Coley Cancer Research Program as
  553  specified in ss. 215.5602, 288.955, 381.915, and 381.922. The
  554  trust fund is exempt from the service charges imposed by s.
  555  215.20.
  556         Section 9. Paragraph (c) of subsection (2) of section
  557  210.20, Florida Statutes, is amended to read:
  558         210.20 Employees and assistants; distribution of funds.—
  559         (2) As collections are received by the division from such
  560  cigarette taxes, it shall pay the same into a trust fund in the
  561  State Treasury designated “Cigarette Tax Collection Trust Fund”
  562  which shall be paid and distributed as follows:
  563         (c) Beginning July 1, 2017, and continuing through June 30,
  564  2033, the division shall from month to month certify to the
  565  Chief Financial Officer the amount derived from the cigarette
  566  tax imposed by s. 210.02, less the service charges provided for
  567  in s. 215.20 and less 0.9 percent of the amount derived from the
  568  cigarette tax imposed by s. 210.02, which shall be deposited
  569  into the Alcoholic Beverage and Tobacco Trust Fund, specifying
  570  an amount equal to 1 percent of the net collections, not to
  571  exceed $3 million annually, and that amount shall be deposited
  572  into the Biomedical Research Trust Fund in the Department of
  573  Health. These funds are appropriated annually from the
  574  Biomedical Research Trust Fund for the advancement of cures for
  575  cancers afflicting pediatric populations through basic or
  576  applied research, including, but not limited to, clinical trials
  577  and nontoxic drug discovery. These funds are not included in the
  578  calculation for the distribution of funds pursuant to s.
  579  381.915; however, these funds shall be distributed to cancer
  580  centers participating in the Casey DeSantis Cancer Research
  581  Florida Consortium of National Cancer Institute Centers Program
  582  in the same proportion as is allocated to each cancer center in
  583  accordance with s. 381.915 and are in addition to any funds
  584  distributed pursuant to that section.
  585         Section 10. Subsection (3) of section 409.816, Florida
  586  Statutes, is amended to read:
  587         409.816 Limitations on premiums and cost sharing.—The
  588  following limitations on premiums and cost sharing are
  589  established for the program.
  590         (3) Enrollees in families with a family income above 150
  591  percent of the federal poverty level who are not receiving
  592  coverage under the Medicaid program or who are not eligible
  593  under s. 409.814(7) s. 409.814(6) may be required to pay
  594  enrollment fees, premiums, copayments, deductibles, coinsurance,
  595  or similar charges on a sliding scale related to income, except
  596  that the total annual aggregate cost sharing with respect to all
  597  children in a family may not exceed 5 percent of the family’s
  598  income. However, copayments, deductibles, coinsurance, or
  599  similar charges may not be imposed for preventive services,
  600  including well-baby and well-child care, age-appropriate
  601  immunizations, and routine hearing and vision screenings.
  602         Section 11. This act shall take effect July 1, 2022.